Actively Recruiting

Age: 18Years +
All Genders
NCT06845410

Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study

Led by Peking Union Medical College Hospital · Updated on 2025-11-19

120

Participants Needed

1

Research Sites

87 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a cohort study to investigate the clinical features, current treatment and clinical outcomes in patients with inflammation-associated non-rapidly-progressive coronary artery disease (INR-CAD).

CONDITIONS

Official Title

Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older, male or female.
  • Negative urine or blood pregnancy test for females who can become pregnant.
  • Clinical diagnosis of INR-CAD confirmed by angiographic evidence of coronary lesions (≥ 50% stenosis).
  • Evidence of chronic inflammation within the past 24 months, shown by positive inflammatory markers, autoantibodies, chronic inflammatory disease diagnosis, or immunosuppressive therapy.
  • Do not meet criteria for rapidly-progressive inflammation-associated coronary artery disease (IR-CAD).
  • Will receive or have received a 24-month clinical follow-up for INR-CAD.
Not Eligible

You will not qualify if you...

  • Other moderate to severe heart diseases (congenital, valvular, myocarditis, cardiomyopathy, pericardial diseases, pulmonary hypertension, heart failure, arrhythmia).
  • Active cancer diagnosed within the past 12 months or requiring ongoing treatment.
  • Failure of vital organs.
  • Life expectancy less than 1 year.
  • Pregnant, breastfeeding, or planning pregnancy during the study.
  • History of drug addiction or alcohol abuse risking non-compliance.
  • Previous participation in this study.
  • Participation in another study within the last 30 days.
  • Involvement in planning or conducting this study.
  • Any condition that makes participation unsuitable as judged by investigators.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China, 100730

Actively Recruiting

Loading map...

Research Team

Z

Zhenyu Liu, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here